Atlas Trials

Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML

Clinical trial NCT03597321 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03597321
Sponsor
Institut Paoli-Calmettes
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2020-09-07
Primary completion
2027-05-01
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.